The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Flow cytometric analysis of glycosylphosphatidylinositol (GPI) anchor protein on GPI defective mutant cells. GPI defective mutant cells were stained with Biotin Mouse Anti-Human CD59 (Cat. No. 555762; solid line histogram) or Biotin Mouse IgG2a, κ Isotype Control (Cat. No. 555572; dashed line histogram), and PE Streptavidin (Cat. No. 554061). The fluorescence histograms were derived from gated events with the forward and side light-scattering characteristics of viable cells. Flow cytometry was performed on a BD FACScan™.
Flow cytometric analysis of glycosylphosphatidylinositol (GPI) anchor protein cells on K562 cells. K562 cells were stained with Biotin Mouse Anti-Human CD59 (Cat. No. 555762; solid line histogram) or Biotin Mouse IgG2a, κ Isotype Control (Cat. No. 555572; dashed line histogram) and PE Streptavidin (Cat. No. 554061). The fluorescence histograms were derived from gated events with the forward and side light-scattering characteristics of viable cells. Flow cytometry was performed on a BD FACScan™.
Flow cytometric analysis of glycosylphosphatidylinositol (GPI) anchor protein on GPI defective mutant cells. GPI defective mutant cells were stained with Biotin Mouse Anti-Human CD59 (Cat. No. 555762; solid line histogram) or Biotin Mouse IgG2a, κ Isotype Control (Cat. No. 555572; dashed line histogram), and PE Streptavidin (Cat. No. 554061). The fluorescence histograms were derived from gated events with the forward and side light-scattering characteristics of viable cells. Flow cytometry was performed on a BD FACScan™.
Flow cytometric analysis of glycosylphosphatidylinositol (GPI) anchor protein cells on K562 cells. K562 cells were stained with Biotin Mouse Anti-Human CD59 (Cat. No. 555762; solid line histogram) or Biotin Mouse IgG2a, κ Isotype Control (Cat. No. 555572; dashed line histogram) and PE Streptavidin (Cat. No. 554061). The fluorescence histograms were derived from gated events with the forward and side light-scattering characteristics of viable cells. Flow cytometry was performed on a BD FACScan™.
Flow cytometric analysis of glycosylphosphatidylinositol (GPI) anchor protein on GPI defective mutant cells. GPI defective mutant cells were stained with Biotin Mouse Anti-Human CD59 (Cat. No. 555762; solid line histogram) or Biotin Mouse IgG2a, κ Isotype Control (Cat. No. 555572; dashed line histogram), and PE Streptavidin (Cat. No. 554061). The fluorescence histograms were derived from gated events with the forward and side light-scattering characteristics of viable cells. Flow cytometry was performed on a BD FACScan™.
Flow cytometric analysis of glycosylphosphatidylinositol (GPI) anchor protein cells on K562 cells. K562 cells were stained with Biotin Mouse Anti-Human CD59 (Cat. No. 555762; solid line histogram) or Biotin Mouse IgG2a, κ Isotype Control (Cat. No. 555572; dashed line histogram) and PE Streptavidin (Cat. No. 554061). The fluorescence histograms were derived from gated events with the forward and side light-scattering characteristics of viable cells. Flow cytometry was performed on a BD FACScan™.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The p282 (HI9) monoclonal antibody specifically binds to CD59, a 19 kDa glycosylphosphatidylinositol (GPI)-anchored glycoprotein, expressed on hematopoietic and non-hematopoietic cells. Because of its interaction with complement activated products, CD59 has been termed membrane-attack-complex-inhibitory factor (MACIF), homologus restriction factor (HRF20), membrane inhibitor of reactive lysis (MIRL) and Protectin. It inhibits the cytolytic activity of the complement system by binding to C8 and C9, thereby blocking the assembly of the membrane attack complex. CD59 also participates in spontaneous T-cell/erythrocyte adhesion, interacts with CD2, and plays a role in T-cell activation.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.